- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06827262
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain (IMPROVE)
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ann Yamano
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
Study Contact Backup
- Name: Diane Keesey
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
Study Locations
-
-
-
Aylesbury, United Kingdom
- Recruiting
- Buckinghamshire Healthcare NHS Trust
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
-
-
Arizona
-
Flagstaff, Arizona, United States, 86001
- Recruiting
- Flagstaff Bone & Joint
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
Phoenix, Arizona, United States, 85014
- Recruiting
- Innovative Pain and Wellness
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
California
-
Larkspur, California, United States, 94939
- Recruiting
- MarinHealth Spine Institute
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
Stanford, California, United States, 94305
- Recruiting
- Stanford University Medical Center
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Connecticut
-
Westport, Connecticut, United States, 06880
- Recruiting
- The Spine Wellness Center in Westport
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20010
- Recruiting
- Washington Hospital Center
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Florida
-
Orlando, Florida, United States, 32806
- Recruiting
- Orlando Regional Medical Center
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Georgia
-
Jasper, Georgia, United States, 30143
- Recruiting
- Horizon Clinical Research, LLC
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Idaho
-
Post Falls, Idaho, United States, 83854
- Withdrawn
- North Idaho Day Surgery, LLC
-
-
Illinois
-
Barrington, Illinois, United States, 60010
- Recruiting
- Illinois Bone and Joint Institute
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Kentucky
-
Lexington, Kentucky, United States, 40509
- Recruiting
- Commonwealth Pain and Spine
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70115
- Recruiting
- Ochsner Clinic Foundation
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Minnesota
-
Maple Grove, Minnesota, United States, 55369
- Recruiting
- iSpine Clinics
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
Saint Cloud, Minnesota, United States, 56303
- Recruiting
- CentraCare Health System
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
New York
-
Port Jefferson Station, New York, United States, 11776
- Recruiting
- New York Spine and Pain Specialists
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
Rochester, New York, United States, 14618
- Active, not recruiting
- University of Rochester
-
The Bronx, New York, United States, 10461
- Recruiting
- Montefiore Medical Center
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
North Carolina
-
Bermuda Run, North Carolina, United States, 27106
- Recruiting
- Novant Health Spine Specialists
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Oregon
-
Eugene, Oregon, United States, 97404
- Active, not recruiting
- Pacific Sports and Spine
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15212
- Recruiting
- Allegheny General Hospital
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Texas
-
Houston, Texas, United States, 77065
- Recruiting
- Cy-Pain and Spine
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Utah
-
Salt Lake City, Utah, United States, 84108
- Recruiting
- University of Utah Orthopaedic Center
-
Contact:
- Boston Scientific Clinical Research
- Phone Number: 855-213-9890
- Email: BSNClinicalTrials@bsci.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Subjects are established patients in a medical practice who will receive intraosseous nerve ablation to treat vertebrogenic pain utilizing a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use according to standard of care.
Description
Inclusion Criteria:
- Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
- Signed a valid, IRB/EC-approved informed consent form.
Exclusion Criteria:
- Meets any contraindications per locally applicable Instructions for Use (IFU).
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intracept™ Intraosseous Nerve Ablation Systems
Subjects with pain treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System |
Intracept™ Intraosseous Nerve Ablation for treatment of patients diagnosed with vertebrogenic pain |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Disability (Oswestry Disability Index (ODI) from Baseline
Time Frame: 60-months post-procedure
|
The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points. |
60-months post-procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Natalie Bloom Lyons, M.A., Boston Scientific Corporation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REL025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.